Medline Inc. Class A common stock (MDLN) is a publicly traded the market company. As of July 5, 2026, MDLN trades at $43.19 with a market cap of $36.52B and a P/E ratio of 0.00. MDLN moved +3.52% today. Year to date, MDLN is +3.03%; over the trailing twelve months it is flat. Its 52-week range spans $32.82 to $50.88. Analyst consensus is strong buy with an average price target of $51.89. Rallies surfaces MDLN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Medline to Add Slovakia Plant with Clean Room, BREEAM-Efficient Capacity by 2027: Medline is constructing a new clean room-equipped facility adjacent to its existing Partizánske, Slovakia plant, expanding manufacturing capacity to support European growth. Production is scheduled to begin in 2027, and the BREEAM Excellent–designed facility will include solar energy systems and create additional jobs.
| Metric | Value |
|---|---|
| Price | $43.19 |
| Market Cap | $36.52B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $50.88 |
| 52-Week Low | $32.82 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $29.14B |
| Net Income | $1.08B |
| Gross Margin | 25.86% |
20 analysts cover MDLN: 0 strong buy, 18 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $51.89.